INNOVATE (VATE) - 2025 Q1 - Quarterly Results

FOR IMMEDIATE RELEASE INNOVATE Corp. Announces First Quarter 2025 Results - Infrastructure: DBM Global first quarter revenue of $264.9 million - - Life Sciences: MediBeacon Transdermal GFR ("TGFR") System Received FDA Approval to Assess Kidney Function - ® - Spectrum: Expects commercial opportunities in datacasting to generate revenue by the end of the year - NEW YORK, NY, May 6, 2025 - INNOVATE Corp. ("INNOVATE" or the "Company") (NYSE: VATE) announced today its consolidated results for the first quarter. ...